Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Machine learning models can be trained to predict chronic diseases such as dementia using electronic medical record (EMR) data, according to a new study published in Artificial Intelligence in Medicine.
Oncopole, a Montreal-based research center, announced that five teams won the Onco-Tech Competition and will receive a total of $1.97 ($2.6 million CAD) in funding.
Civica Rx, the not-for-profit drug company startup created by a group of hospitals and health systems to reduce drug shortages, is prepared to ship its first eight injectable medicines.
Humana is launching two new partnerships in four states to better care for its Medicare Advantage and commercially insured members who have kidney care.
Amazon’s online pharmacy business, PillPack, has integrated with Blue Cross Blue Shield of Massachusetts to help members of the health plan manage their medications.
Deep learning models can improve the detection of attention deficit hyperactivity disorder (ADHD), according to new findings published in Radiology: Artificial Intelligence.
Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.
The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals.
As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”
